These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15553215)

  • 1. The value of USP public standards for therapeutic products.
    Bhattacharyya L; Cecil T; Dabbah R; Roll D; Schuber S; Sheinin EB; Williams RL;
    Pharm Res; 2004 Oct; 21(10):1725-31. PubMed ID: 15553215
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 3. Ingredients in pharmaceutical preparations: a problem not value.
    Lubner GC
    Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 6. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2009; (953):1-161. PubMed ID: 19621561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary standards--the USP and the PDA.
    Schmitz AJ
    J Parenter Drug Assoc; 1980; 34(6):425-6. PubMed ID: 6906364
    [No Abstract]   [Full Text] [Related]  

  • 9. USP and the Drug Regulation Reform Act.
    Heller WM
    J Parenter Drug Assoc; 1979; 33(2):55-60. PubMed ID: 255147
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group.
    Weitzel J; Pappa H; Banik GM; Barker AR; Bladen E; Chirmule N; DeFeo J; Devine J; Emrick S; Hout TK; Levy MS; Mahlangu GN; Rellahan B; Venema J; Workman W
    AAPS J; 2021 Oct; 23(6):112. PubMed ID: 34654974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information chapters in pharmacopoeias.
    Banes D
    Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars).
    Thorpe R; Wadhwa M
    Biologicals; 2011 Sep; 39(5):262-5. PubMed ID: 21880508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug product equivalence--the problem, the challenge and the USP.
    Macek TJ
    J Am Pharm Assoc; 1972 Jan; 12(1):26-8. PubMed ID: 5007260
    [No Abstract]   [Full Text] [Related]  

  • 16. Public standards for drugs: reflections on their use by the professions and industry.
    Miller LC
    Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
    [No Abstract]   [Full Text] [Related]  

  • 17. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 18. Extemporaneously compounded sterile medications: relevance of new United States pharmacopeial standards to pain clinicians.
    Rusho WJ
    J Pain Palliat Care Pharmacother; 2004; 18(4):69-76. PubMed ID: 15760810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.